Description
An AMPK activator at a concentration of 150 µM in platelets; inhibits thrombin-, ADP-, and collagen-induced platelet aggregation (IC50s = 84, 55, and 87 µM, respectively); inhibits whole blood aggregation; improves glucose tolerance in mouse models of diabetes
Formal name: 3-[[(3E)-3-[(4-chlorophenyl)phenylmethylene]-2,3-dihydro-2-oxo-1H-indol-1-yl]methyl]-benzoic acid
Synonyms:
Molecular weight: 465.9
CAS: 1273323-67-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|CaMKs||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cardiovascular System|Blood|Thrombosis||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Nutrient Sensing